JZL195
| CAS No. | 1210004-12-8 | Cat. No. | BCP23894 |
| Name | JZL195 | ||
| Synonyms | JZL-195; JZL 195; | ||
| Formula | C24H23N3O5 | M. Wt | 433.46 |
| Description | JZL195 is a potent and selective dual inhibitor of FAAH and monacylglycerol lipase (MAGL). JZL195 has greater anti-allodynic efficacy than selective FAAH, or MAGL inhibitors, plus a greater therapeutic window than a cannabinoid receptor agonist. JZL195 may have greater potential in alleviating neuropathic pain, compared to selective FAAH and MAGL inhibitors, or cannabinoid receptor agonists. | ||
| Pathways | Protease/Metabolic Enzyme Neuro Signaling Pathway | ||
| Targets | MAGL FAAH | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.